HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vaccination with dendritic cells pulsed ex vivo with gp100 peptide-decorated liposomes enhances the efficacy of anti PD-1 therapy in a mouse model of melanoma.

AbstractBACKGROUND:
Targeting antigens to dendritic cells (DCs) via nanoparticles is a powerful strategy which improves the efficacy of ex vivo antigen-pulsed DC vaccines.
METHODS:
In this study, liposomes were first decorated with gp10025-33 self-antigen and then characterized. Then, DCs were pulsed ex vivo with liposomal gp100 and injected subcutaneously in mice bearing B16F10 established melanoma tumors in combination with anti-PD-1 therapy.
RESULTS:
Treatment with liposomal pulsed DC vaccine elicited the strongest anticancer immunity and enhanced intratumoral immune responses based on infiltration of gp100-specific CD4+ and CD8+ T cells to the tumor leading to significant tumor growth regression and prolonged survival rate. Treatment with liposomal pulsed DC vaccine also markedly enhanced specific cytotoxic T lymphocytes (CTL) responses with a significant higher titer of IFN-γ in the spleen. Moreover, a significant increase of PD-1 expressing CD8+ tumor infiltrating lymphocytes (TILs) was detected in tumors.
CONCLUSION:
Our results demonstrate an optimum dose of liposomal gp100 significantly increases the efficacy of anti-PD-1 therapy in mice and might be an effective strategy to overcome resistance to anti-PD-1 therapy.
AuthorsMona Yazdani, Zahra Gholizadeh, Amin Reza Nikpoor, Mahdi Hatamipour, Behrang Alani, Hossein Nikzad, Nema Mohamadian Roshan, Javad Verdi, Mahmoud Reza Jaafari, Mahdi Noureddini, Ali Badiee
JournalVaccine (Vaccine) Vol. 38 Issue 35 Pg. 5665-5677 (07 31 2020) ISSN: 1873-2518 [Electronic] Netherlands
PMID32653275 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2020 Elsevier Ltd. All rights reserved.
Chemical References
  • Cancer Vaccines
  • Liposomes
  • Membrane Glycoproteins
  • Neoplasm Proteins
  • Peptides
  • gp100 Melanoma Antigen
Topics
  • Animals
  • Cancer Vaccines
  • Dendritic Cells
  • Liposomes
  • Melanoma (therapy)
  • Membrane Glycoproteins
  • Mice
  • Neoplasm Proteins
  • Peptides
  • T-Lymphocytes, Cytotoxic
  • Vaccination
  • gp100 Melanoma Antigen

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: